SLC2A1 and breast carcinoma: On account of the above, the aim of this study was to evaluate the expression of HIF-1α, GLUT1 and CAIX in peripheral blood samples taken from breast cancer patients as well as in samples of tumor tissue and peripheral blood from healthy donors.